Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Tue, 01st Jun 2021 15:51

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Tekmar Group PLC - provider of technology and services for offshore energy markets - Hires Derek Bulmer as new chief financial officer. Sue Hurst, the current CFO, steps down from the role on Tuesday but will remain on the board for a transition period. Bulmer was CFO and in-house counsel for AIM-listed radiation detection technology firm Kromek Group PLC from 2010 until last year. Prior to Kromek, he had worked at brick maker Ibstock PLC, among other employers. Tekmar also announced its annual results on Tuesday. For the 12 months ended March 31, it swung to pretax loss of GBP2.5 million from a profit of GBP2.0 million the year before, on revenue which declined 29% to GBP29.1 million from GBP40.9 million.

----------

Redx Pharma PLC - Macclesfield, England-based discovery of treatments for cancer and fibrotic disease - Chair Iain Ross steps down as a director immediately "to pursue other business opportunities". Redx makes Independent Non-Executive Director Peter Presland the interim chair as it starts search for new chair. "Iain has been the lynchpin in the turnaround of Redx, and we are very grateful for his innumerable contributions as chairman over the last four years," says Chief Executive Officer Lisa Anson. Ross says he remains "a supportive shareholder".

----------

Chamberlin PLC - West Midlands-based castings and engineering - New CEO Kevin Price and new Finance Director Alan Tomlinson join the board on Tuesday. Non-Executive Director Trevor Brown moves to executive director, responsible for company strategy, effective immediately, while David Flowerday resigns as non-executive director from Monday.

----------

Challenger Energy Group PLC - assets in Bahamas, Uruguay, Trinidad & Tobago and Suriname, previously known as Bahamas Petroleum Co PLC - Eytan Uliel formally takes up role as CEO. Simon Potter steps down as CEO but remains as non-executive director. Stephen Bizzell joins board as non-executive director, replacing Ross McDonald.

----------

Longboat Energy PLC - North Sea-focused exploration and production - Hires Nick Ingrassia as corporate development director. Ingrassia had joined Longboat back in September. Among other roles, he had worked at Faroe Petroleum PLC, whose former management team are behind Longboat Energy. Ingrassia's appointment comes alongside Longboat's announcement on Tuesday of three acquisitions to develop an exploration drilling programme on the Norwegian continental shelf. The acquisitions will be accompanied by a GBP35 million equity raise and are classified as a reverse takeover of Longboat under AIM rules.

----------

Trustpilot AS - Copenhagen-based online consumer reviews platform - Hires Joe Hurd as independent non-executive director. California-based Hurd is an independent public board director and adviser.

----------

India Capital Growth Fund Ltd - invests directly, or indirectly, in companies based in India - Hires Lynne Duquemin as non-executive director, effective immediately, as successor to Peter Niven, who will retire from the board at the end of 2021. Duquemin is a Guernsey resident with "deep experience of investment management and advisory services".

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Nov 2018 12:52

Redx Pharma Showcases Positive Preclinical Trial Results Of RXC004

LONDON (Alliance News) - Redx Pharma PLC on Monday reported a positive data from preclinical studies evaluating RXC004.The results were presented at the National Cancer Research Institute a

Read more
29 Oct 2018 14:50

Redx CEO Lisa Anson elected to Bioindustry Association board

(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected to serve on the BIA board of directors.

Read more
24 Apr 2018 11:17

Redx Pharma Hires AstraZeneca UK President As Chief Executive

LONDON (Alliance News) - Shares jumped in Redx Pharma PLC on Tuesday as it announced the appointment of AstraZeneca PLC executive Lisa Anson as chief executive officer with effect on June in the I

Read more
22 Mar 2018 13:43

Redx Pharma Signs Agreement For Anti-Infective Programme With Deinove

LONDON (Alliance News) - Drug development company Redx Pharma PLC said Thursday that it has signed an option and licence agreement with chemicals company Deinove SAS for Novel

Read more
9 Feb 2017 14:21

RedX Pharma as it proposes discounted capital raising

(ShareCast News) - Shares in RedX Pharma are down almost 5% as it proposes raising £12m, before expenses, via a placing and subscription to advance its drugs pipeline. The proposed placing was of up to 20.5m shares, while the subscription was of 11.5m shares by Lanstead Capital, an institutional inv

Read more
30 Nov 2016 10:13

Redx Pharma To Present Pre-Clinical Profile Of RXC004 At Conference

Read more
20 Oct 2016 11:34

Redx Pharma identifies candidate for inhibitor programme

(ShareCast News) - Drug-development company Redx Pharma has identified a candidate for its reversible Bruton's tyrosine kinase (BTK) inhibitor programme. The compound, named RXC005, has the potential to treat the majority of patients suffering from chronic lymphocytic leukaemia (CLL), including tho

Read more
20 Oct 2016 08:33

Redx Pharma Selects Drug Candidate To Treat Leukaemia

Read more
27 Sep 2016 09:33

WINNERS & LOSERS SUMMARY: Wolseley Sold Amid Job Cuts, No Extra Payout

Read more
19 Sep 2016 08:13

Redx Pharma Sees Cancer Immunotherapy Promise For Porcupine Inhibitor

Read more
11 Sep 2016 15:25

Sunday share tips: Dunelm Group, Green REIT, Redx Pharma

(ShareCast News) - Buy shares in Dunelm Group, said the Sunday Times' Inside the City column. On Wednesday the home furnishings retailer is due to publish its first annual results under new chief executive John Browett. In the final three months of the year the FSTE 250 company - a sort of cut-price

Read more
24 May 2016 09:33

Redx Pharma Loss Widens But Notes Oncology Lead Progress

Read more
19 May 2016 10:17

Redx Pharma Welcomes Paper On Tackling Antimicrobial Resistance

Read more
9 May 2016 07:46

Redx Pharma Appoints David Lawrence Non-Executive Director

Read more
24 Mar 2016 14:08

Redx Pharma Raising GBP10.0 Million To Progress Its Pipeline (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.